Working with ovarian carcinoma cells, Pradeep et al. (2015), shown that EPO was recognized by Ephrin receptor B4 (EphB4) which is well known through its interaction with Ephrin B2 (EphB2). Here, EPHB4 is linked to ovarian carcinoma.